TRISALUS LIFE SCIENCES INC (TLSI) Fundamental Analysis & Valuation

NASDAQ:TLSI • US89680M1018

Current stock price

4.32 USD
+0.06 (+1.41%)
At close:
4.32 USD
0 (0%)
After Hours:

This TLSI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TLSI Profitability Analysis

1.1 Basic Checks

  • In the past year TLSI has reported negative net income.
  • In the past year TLSI has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: TLSI reported negative net income in multiple years.
  • In the past 5 years TLSI always reported negative operating cash flow.
TLSI Yearly Net Income VS EBIT VS OCF VS FCFTLSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • TLSI has a worse Return On Assets (-201.28%) than 89.13% of its industry peers.
Industry RankSector Rank
ROA -201.28%
ROE N/A
ROIC N/A
ROA(3y)-198.15%
ROA(5y)-113.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TLSI Yearly ROA, ROE, ROICTLSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

  • TLSI has a better Gross Margin (84.57%) than 86.99% of its industry peers.
  • The Profit Margin and Operating Margin are not available for TLSI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TLSI Yearly Profit, Operating, Gross MarginsTLSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. TLSI Health Analysis

2.1 Basic Checks

  • TLSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TLSI has more shares outstanding than it did 1 year ago.
  • TLSI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, TLSI has a worse debt to assets ratio.
TLSI Yearly Shares OutstandingTLSI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
TLSI Yearly Total Debt VS Total AssetsTLSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • TLSI has an Altman-Z score of -11.33. This is a bad value and indicates that TLSI is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of TLSI (-11.33) is worse than 75.34% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -11.33
ROIC/WACCN/A
WACC9.99%
TLSI Yearly LT Debt VS Equity VS FCFTLSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M 200M

2.3 Liquidity

  • TLSI has a Current Ratio of 2.80. This indicates that TLSI is financially healthy and has no problem in meeting its short term obligations.
  • TLSI has a worse Current ratio (2.80) than 65.05% of its industry peers.
  • A Quick Ratio of 2.54 indicates that TLSI has no problem at all paying its short term obligations.
  • TLSI's Quick ratio of 2.54 is on the low side compared to the rest of the industry. TLSI is outperformed by 67.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.8
Quick Ratio 2.54
TLSI Yearly Current Assets VS Current LiabilitesTLSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. TLSI Growth Analysis

3.1 Past

  • TLSI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.79%, which is quite good.
  • TLSI shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.81%.
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.5%
Revenue 1Y (TTM)25.81%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%59.85%

3.2 Future

  • TLSI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.90% yearly.
  • Based on estimates for the next years, TLSI will show a very strong growth in Revenue. The Revenue will grow by 32.25% on average per year.
EPS Next Y65.76%
EPS Next 2Y39.2%
EPS Next 3Y30.9%
EPS Next 5YN/A
Revenue Next Year34.39%
Revenue Next 2Y35.97%
Revenue Next 3Y35.89%
Revenue Next 5Y32.25%

3.3 Evolution

TLSI Yearly Revenue VS EstimatesTLSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M 250M
TLSI Yearly EPS VS EstimatesTLSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 0 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. TLSI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TLSI. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TLSI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLSI Price Earnings VS Forward Price EarningsTLSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TLSI Per share dataTLSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • TLSI's earnings are expected to grow with 30.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.2%
EPS Next 3Y30.9%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TLSI Dividend Analysis

5.1 Amount

  • TLSI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TLSI Fundamentals: All Metrics, Ratios and Statistics

TRISALUS LIFE SCIENCES INC

NASDAQ:TLSI (4/30/2026, 8:20:20 PM)

After market: 4.32 0 (0%)

4.32

+0.06 (+1.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength55.9
Industry Growth13.04
Earnings (Last)01-12
Earnings (Next)05-14
Inst Owners18.9%
Inst Owner Change9.61%
Ins Owners9.02%
Ins Owner Change8.42%
Market Cap265.29M
Revenue(TTM)45.15M
Net Income(TTM)-71.12M
Analysts81.82
Price Target9.38 (117.13%)
Short Float %3%
Short Ratio6.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.67%
Min EPS beat(2)-64.97%
Max EPS beat(2)-56.36%
EPS beat(4)0
Avg EPS beat(4)-54.06%
Min EPS beat(4)-73.8%
Max EPS beat(4)-21.11%
EPS beat(8)3
Avg EPS beat(8)-13.25%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.75%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)2.08%
Revenue beat(4)2
Avg Revenue beat(4)0.2%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.81%
Revenue beat(8)4
Avg Revenue beat(8)0.65%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)-55.37%
EPS NY rev (3m)-49.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-25.13%
Revenue NY rev (1m)-0.74%
Revenue NY rev (3m)-4.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.88
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.12
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0.74
BVpS-0.55
TBVpS-0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -201.28%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.57%
FCFM N/A
ROA(3y)-198.15%
ROA(5y)-113.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 146.65%
Cap/Sales 2.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.8
Quick Ratio 2.54
Altman-Z -11.33
F-Score2
WACC9.99%
ROIC/WACCN/A
Cap/Depr(3y)92.99%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.13%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.5%
EPS Next Y65.76%
EPS Next 2Y39.2%
EPS Next 3Y30.9%
EPS Next 5YN/A
Revenue 1Y (TTM)25.81%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%59.85%
Revenue Next Year34.39%
Revenue Next 2Y35.97%
Revenue Next 3Y35.89%
Revenue Next 5Y32.25%
EBIT growth 1Y25.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.15%
EBIT Next 3Y37.06%
EBIT Next 5Y27.68%
FCF growth 1Y54.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.9%
OCF growth 3YN/A
OCF growth 5YN/A

TRISALUS LIFE SCIENCES INC / TLSI Fundamental Analysis FAQ

What is the fundamental rating for TLSI stock?

ChartMill assigns a fundamental rating of 2 / 10 to TLSI.


What is the valuation status of TRISALUS LIFE SCIENCES INC (TLSI) stock?

ChartMill assigns a valuation rating of 1 / 10 to TRISALUS LIFE SCIENCES INC (TLSI). This can be considered as Overvalued.


How profitable is TRISALUS LIFE SCIENCES INC (TLSI) stock?

TRISALUS LIFE SCIENCES INC (TLSI) has a profitability rating of 1 / 10.